• Study of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    Poland

  • Study on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study of Atezolizumab treatment in patients with metastatic bladder cancer (urothelial cancer) after radical cystectomy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

    Not recruiting

    3 1
    Investigated Diseases:
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Czechia France Germany Hungary Poland +1

  • Study of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany Greece Hungary Italy The Netherlands +2

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Estonia France Greece Italy Norway +3

  • Study on the Effectiveness and Safety of MC2-25 Cream for Itching in Chronic Kidney Disease Patients

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Hungary Poland

  • Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark Finland France +10

powered by